Editor Cindy Papp interviewed four top physicians, Drs. Jeffrey Dover, Ashish Bhatia, Emmy Graber, and Tahl Humes, about their early experience treating patients with AviClear™, the first and only FDA-cleared device that can treat mild, moderate and severe acne vulgaris.
Until now, the leading acne treatments were systemic, often accompanied by side effects that impeded some patients from obtaining treatment and led to aesthetic physicians passing acne patients to their dermatologist peers. But that is about to change.
Dermatologists and aesthetic physicians can now treat all acne severities with a safe and effective device with no risk of harmful side effects. AviClear will soon be the preferred choice to clear acne, especially for patients are seeking a drug-free yet effective solution.
“Developing AviClear was an endeavor that kept patients and modern lifestyles top of mind with demands for an easy-to-follow treatment and satisfactory results at the forefront.”
The Future of Acne Treatment with AviClear
“Patients of any skin type can be treated safely with good results, and they found the treatment comfortable as no patient dropped out of the study due to pain. This offers hope for patients who have not had success with other treatments, whether it be oral antibiotics, topicals, lasers or isotretinoin (Accutane®),” said Ashish Bhatia, MD, co-founder of Oak Dermatology in Illinois.
“With AviClear, patients do not have to change their lifestyle, making this treatment protocol easy to follow with continued improvements as a result.”